A 52-year-old man with acute onset fever, productive cough with rusty sputum, and pleuritic chest pain presents to the hospital. Chest X-ray shows consolidation in the right lower lobe. Blood culture is positive for Streptococcus pneumoniae. What is the drug of choice for community-acquired lobar pneumonia in this patient?

Explanation

## Community-Acquired Lobar Pneumonia — First-Line Treatment ### Clinical Context Lobar pneumonia is classically caused by *Streptococcus pneumoniae* and presents with acute onset, high fever, and consolidation in a single lobe. The patient's rusty sputum and positive blood culture confirm pneumococcal lobar pneumonia. ### Drug of Choice **Key Point:** Ceftriaxone (third-generation cephalosporin) is the first-line agent for community-acquired lobar pneumonia caused by *S. pneumoniae*, especially when bacteremia is present. ### Why Ceftriaxone? 1. **Excellent lung penetration** — achieves high concentrations in lung tissue and pleural fluid 2. **Broad spectrum** — covers *S. pneumoniae*, *H. influenzae*, and gram-negative organisms 3. **Bactericidal** — superior to macrolides for invasive pneumococcal disease 4. **Guideline standard** — recommended by IDSA and Indian chest society guidelines for CAP with bacteremia ### Comparison with Other Options | Agent | Use Case | Limitation | |-------|----------|----------| | Amoxicillin-clavulanate | Oral step-down after IV therapy; mild CAP | Inadequate for bacteremic pneumonia; poor lung penetration | | Ceftriaxone | **First-line IV for lobar pneumonia with bacteremia** | None for this indication | | Fluoroquinolone (levofloxacin) | Atypical organisms; alternative if allergy | Not preferred for invasive pneumococcal disease | | Azithromycin | Atypical coverage only; adjunctive | Monotherapy inadequate for pneumococcal lobar pneumonia | ### High-Yield Distinction **High-Yield:** Lobar pneumonia (acute onset, single lobe, bacteremia) → **Cephalosporin (ceftriaxone)**. Bronchopneumonia (insidious, patchy, elderly/debilitated) → broader coverage depending on organism. ### Clinical Pearl **Clinical Pearl:** In a patient with positive blood culture and lobar consolidation, ceftriaxone should be initiated empirically without waiting for sensitivities, as it covers the most likely pathogen (*S. pneumoniae*) and has excellent bactericidal activity.